InvestorsHub Logo

DewDiligence

08/18/17 11:01 AM

#1487 RE: DewDiligence #1483

Maviret* approved in Canada:

https://finance.yahoo.com/news/abbvies-maviret-approved-health-canada-130300201.html

ENTA does not receive a milestone payment from ABBV for Maviret approval in Canada, but they do get a $15M milestone payment from ABBV for approval in Japan, which is expected in the next two quarters.

*Note spelling, which is the same as the brand name in the EU but differs from the “Mavyret” brand name in the US.

DewDiligence

09/27/17 9:44 AM

#1505 RE: DewDiligence #1483

Japan approves Maviret, triggering $15M milestone payment: #msg-134935488.

DewDiligence

10/27/17 9:28 AM

#1532 RE: DewDiligence #1483

Mavyret 3Q17 sales (partial quarter) ~$100M: #msg-135740870.